Free Trial

National Vision (NASDAQ:EYE) Releases FY 2024 Earnings Guidance

National Vision logo with Medical background

National Vision (NASDAQ:EYE - Get Free Report) updated its FY 2024 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 0.450-0.500 for the period, compared to the consensus estimate of 0.480. The company issued revenue guidance of $1.8 billion-$1.8 billion, compared to the consensus revenue estimate of $1.8 billion. National Vision also updated its FY24 guidance to $0.45-$0.50 EPS.

Wall Street Analyst Weigh In

Several research firms have commented on EYE. The Goldman Sachs Group dropped their target price on shares of National Vision from $20.00 to $13.00 and set a "neutral" rating on the stock in a research report on Friday, August 9th. UBS Group dropped their target price on shares of National Vision from $20.00 to $18.00 and set a "buy" rating on the stock in a research report on Thursday, August 8th. Finally, Barclays dropped their target price on shares of National Vision from $16.00 to $11.00 and set an "equal weight" rating on the stock in a research report on Thursday, August 8th. Three research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, National Vision has a consensus rating of "Hold" and a consensus price target of $15.25.

Get Our Latest Stock Analysis on National Vision

National Vision Stock Performance

National Vision stock traded down $0.31 during mid-day trading on Wednesday, reaching $11.89. The company's stock had a trading volume of 3,897,130 shares, compared to its average volume of 1,460,263. National Vision has a 12-month low of $9.56 and a 12-month high of $24.11. The company has a market capitalization of $934.98 million, a P/E ratio of -11.54, a PEG ratio of 2.42 and a beta of 1.42. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.41 and a current ratio of 0.55. The firm's fifty day moving average price is $10.43 and its two-hundred day moving average price is $12.66.

National Vision (NASDAQ:EYE - Get Free Report) last released its quarterly earnings results on Wednesday, November 6th. The company reported $0.12 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.06. The firm had revenue of $451.50 million for the quarter, compared to analysts' expectations of $451.13 million. National Vision had a negative net margin of 4.00% and a positive return on equity of 3.53%. The business's quarterly revenue was down 15.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.09 earnings per share. Sell-side analysts predict that National Vision will post 0.23 EPS for the current fiscal year.

National Vision Company Profile

(Get Free Report)

National Vision Holdings, Inc, through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services.

See Also

Earnings History and Estimates for National Vision (NASDAQ:EYE)

Should you invest $1,000 in National Vision right now?

Before you consider National Vision, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Vision wasn't on the list.

While National Vision currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Whitestone REIT is Outperforming in 2024: 35% Growth & Monthly Dividends
Why SoundHound Stock Dip Could Mean Big Gains for 2025 Investors
Nintendo Stock: Buy Before the 2025 Switch Platform Hits!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines